1. Alpha-Lipoic acid supplementation during in vitro culture of abattoir- and OPU-derived bovine oocytes improves embryonic quality.
- Author
-
Fabra MC, Campagna AA, Farnetano N, Anchordoquy JP, Anchordoquy JM, Carranza-Martin AC, Furnus CC, and Nikoloff N
- Subjects
- Animals, Cattle embryology, Female, Embryo Culture Techniques veterinary, Abattoirs, Embryonic Development drug effects, Oocyte Retrieval veterinary, Oocyte Retrieval methods, Culture Media pharmacology, Culture Media chemistry, Thioctic Acid pharmacology, Oocytes drug effects, Oocytes physiology, In Vitro Oocyte Maturation Techniques veterinary, In Vitro Oocyte Maturation Techniques methods
- Abstract
The Ovum Pick-Up (OPU) technique offers a rapid path to genetic improvement. Embryonic genome activation (EGA) is crucial for successful embryonic development and occurs in two phases: minor EGA (MN
EGA ) from 2-cell to 8-cell stages, and major EGA (MJEGA ) from 8-cell to 16-cell stages. Supplementation with alpha-lipoic acid (ALA) during MNEGA using abattoir derived-oocytes has been shown to enhance in vitro embryo production. Two experiments were carried out in the study at hand. Experiment I aimed to evaluate ALA effects on embryo development and quality during MJEGA using abattoir-derived oocytes. Oocytes were treated with either a Control in vitro culture (IVC) medium or 2.5 µM ALA during MJEGA . The ALA presented a trend to increase the blastocyst cell number on day 7 (P = 0.06), along with reducing ROS levels and increasing GSH levels (P ≤ 0.05). Experiment II aimed to verify whether the results from abattoir- derived oocytes could be extrapolated to OPU-derived oocytes. The treatments included a Control, 2.5 µM ALA during MNEGA , and 2.5 µM ALA during MJEGA . The ALA supplementation during MJEGA improved the total blastocyst rate on day 8 (P = 0.04), with a trend towards increased blastocyst cell number on day 7 (P = 0.09). No improvements were observed in MNEGA . Overall, ALA supplementation during MJEGA is more effective than during MNEGA for improving the embryonic quality of OPU-derived oocytes., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)- Published
- 2025
- Full Text
- View/download PDF